RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/B5CB3F84489F1A67B2BC4E8EE38B7AE8A0BDD7E27E48E43807A17575423E937A405C692FEE00030A2DB9673F5B4ABE43http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/B5CB3F84489F1A67B2BC4E8EE38B7AE8A0BDD7E27E48E43807A17575423E937A405C692FEE00030A2DB9673F5B4ABE43http://www.w3.org/2000/01/rdf-schema#comment"Pathogenic autoantibodies to muscle-specific tyrosine kinase (MuSK) can be found in patients with myasthenia gravis (MG) who do not have detectable antibodies to the acetylcholine receptor. Although the autoantibody-mediated pathology is well understood much remains to be learned about the cellular immunology that contributes to autoantibody production. Review."xsd:string
http://purl.uniprot.org/uniprot/#_DF36EB24526A9B17B20CB22FB5D91CFF97F7BC8533495674D31187066CEE1FBBBD5F696AA463DA49E224BF22F82B64A7http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/B5CB3F84489F1A67B2BC4E8EE38B7AE8A0BDD7E27E48E43807A17575423E937A405C692FEE00030A2DB9673F5B4ABE43
http://purl.uniprot.org/uniprot/O15146http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/B5CB3F84489F1A67B2BC4E8EE38B7AE8A0BDD7E27E48E43807A17575423E937A405C692FEE00030A2DB9673F5B4ABE43
http://purl.uniprot.org/uniprot/#_O15146-mappedCitation-29381221http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/B5CB3F84489F1A67B2BC4E8EE38B7AE8A0BDD7E27E48E43807A17575423E937A405C692FEE00030A2DB9673F5B4ABE43